Acceleron Pharma named as one of "Fierce 15" for 2010

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced that it has been selected by the editors of FierceBiotech as one of the "Fierce 15" for 2010, an annual list of the top 15 most promising companies in the biotech industry.

"Acceleron is honored to be chosen by the editors of FierceBiotech as one of this year's Fierce 15, truly an acknowledgement of our company's innovative and creative spirit," said John Knopf, Ph.D., Chief Executive Officer of Acceleron. "Our mission is to bring life-changing therapies to patients in need. The cutting-edge work conducted by Acceleron employees has pioneered a new field of biology and yielded a pipeline of new and powerful therapies that will help make this mission a reality."